Anterogen.Co.,Ltd.

KOSDAQ:A065660 Stock Report

Market Cap: ₩148.2b

Anterogen.Co.Ltd Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Anterogen.Co.Ltd.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth81.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Does Anterogen.Co.Ltd (KOSDAQ:065660) Have A Healthy Balance Sheet?

Apr 04
Does Anterogen.Co.Ltd (KOSDAQ:065660) Have A Healthy Balance Sheet?

Health Check: How Prudently Does Anterogen.Co.Ltd (KOSDAQ:065660) Use Debt?

Feb 05
Health Check: How Prudently Does Anterogen.Co.Ltd (KOSDAQ:065660) Use Debt?

Does Anterogen.Co.Ltd's (KOSDAQ:065660) Share Price Gain of 25% Match Its Business Performance?

Dec 14
Does Anterogen.Co.Ltd's (KOSDAQ:065660) Share Price Gain of 25% Match Its Business Performance?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Anterogen.Co.Ltd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A065660 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20246,659-2,314-317-9N/A
3/31/20246,490-3,450-2,081-1,948N/A
12/31/20236,500-2,841-2,191-1,988N/A
9/30/20236,288-3,228-3,429-3,197N/A
6/30/20236,233-3,703-2,450-2,160N/A
3/31/20236,467-4,192-1,715-1,039N/A
12/31/20226,591-6,837-3,456-1,975N/A
9/30/20227,538-6,452-4,334-2,363N/A
6/30/20227,793-5,347-4,787-2,388N/A
3/31/20228,304-347-5,568-3,545N/A
12/31/20218,122-554-6,040-3,045N/A
9/30/20216,585-1,339-8,316-4,201N/A
6/30/20215,87349-8,895-5,185N/A
3/31/20214,732-6,226-10,096-3,477N/A
12/31/20204,151-4,375-10,151-4,415N/A
9/30/20204,177-6,705-8,109-3,948N/A
6/30/20204,169-8,165-9,013-3,282N/A
3/31/20204,065-4,186-6,821-3,447N/A
12/31/20194,148-4,050-4,667-1,649N/A
9/30/20193,9071,093-3,3531,359N/A
6/30/20193,661359-4,772-1,089N/A
3/31/20193,560-1,522-5,646-939N/A
12/31/20183,607-962-6,517-1,505N/A
9/30/20183,765-3,030-5,639-2,375N/A
6/30/20184,328-1,451-3,507-363N/A
3/31/20184,446-448N/A-778N/A
12/31/20175,357447N/A379N/A
9/30/20175,284163N/A2,453N/A
6/30/20175,066-103N/A1,676N/A
3/31/20174,757-154N/A-131N/A
12/31/20164,896372N/A-131N/A
9/30/20164,813871N/A-1,024N/A
6/30/20165,0011,348N/A257N/A
3/31/20164,9861,337N/A1,773N/A
12/31/20153,532-58N/A844N/A
9/30/20153,241-491N/A-504N/A
6/30/20152,498-1,135N/A-973N/A
3/31/20152,082-1,301N/A-875N/A
12/31/20141,834-1,416N/A-1,010N/A
9/30/20141,575-1,681N/A-1,905N/A
6/30/20141,203-2,080N/A-1,869N/A
3/31/20141,162-1,903N/A-1,568N/A
12/31/2013916-1,810N/A-1,478N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A065660's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if A065660's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A065660's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A065660's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A065660's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A065660's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y